tailieunhanh - Clinical benefit of subsequent chemotherapy after drug-induced interstitial lung disease in pancreatic cancer patients: A multicenter retrospective study from Japan

Drug-induced interstitial lung disease (ILD) is not a rare adverse event in the current chemotherapy strategy for pancreatic ductal adenocarcinoma (PDAC). Thus, we aimed to find the optimal management for PDAC patients with a history of ILD induced by a gemcitabine-based regimen. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN